Mr. David Preiner reports

MEDIVOLVE PROVIDES UPDATE ON ITS MOBILE CLINIC NETWORK

Medivolve Inc. has provided an update on the company's business and operations.

The company's primary business activities are conducted through its wholly owned subsidiary, Collection Sites LLC, which has over 190 employees and has built a network of 22 mobile COVID-19 testing centres across the United States, including in the states of California, Texas, Colorado, Nevada, Indiana and Florida. Each site is a modular pod cube licensed by a lab certified by the U.S. government Department of Health and Human Services.

COVID-19 testing remains an important detection and tool to fight the continuing coronavirus pandemic. David Preiner, chief executive officer of Medivolve, commented: "Governments around the world have lifted restrictions and reduced coronavirus tracking as they grapple with pandemic fatigue; however, new waves of the virus demonstrate that COVID-19 is nowhere near over. Medivolve is proud of its work to continue to offer COVID testing to citizens throughout the United States."

The company is considering expanding its network of mobile COVID-19 testing centres in anticipation of another possible COVID-19 wave fuelled by the BA.4 and BA.5 subvariants. Medivolve continues to look for opportunities to open more testing centres in underserved neighbourhoods.

About Medivolve Inc.

Medivolve is a health care technology company that seeks to reinvent the U.S. health care system by leveraging a bespoke telehealth platform, a clinical diagnostic network and a data-driven AI (artificial intelligence) framework to improve patient care.

The company was born out of the health care crisis to rethink, relearn and, ultimately, reimagine a better way for the health care system to operate. The company's network of retail collection sites play an important role in recovery by giving all Americans access to fast, accurate and inexpensive clinical services when and where they need it. These centres will also play a pivotal role in diagnostic testing, vaccinations and other point-of-care services. Medivolve is building disruptive technologies to make it easier and faster to identify, treat and prevent medical issues. In doing so, the company is working to give patients a holistic and empowered view of their personal health.

Medivolve's long-term mission is to permanently fix systemic issues in the nation's fragmented, overly complex and expensive health care system. Medivolve's next phase of growth is about pivoting the model and putting the pieces together to build a profitable, SaaS-based (software as a service) health technology company. Medivolve is bringing data-driven clinical diagnostics, physician recommendations and prescription medications directly to people, all powered by a singular, streamlined technology network. Medivolve's team is united by a powerful, singular purpose: harnessing the transformative power of technology to create healthier lives.

Underpinned by a bespoke, AI-driven platform, Medivolve is developing a stealth system that constantly gets smarter, takes the guesswork out of diagnostics and flags critical health issues immediately to deliver an unparalleled level of personalization for each patient. Medivolve is determined to push the boundaries of what's possible -- not just for the company's business and the company's shareholders, but for physicians and patients and for the future of health care. Medivolve is striving to achieve a continuity of care never seen before -- a game changer for the company's business and for patients in the communities the company serves.

We seek Safe Harbor.